Ma Jiaze, Chong Jinchen, Qiu Zhengxi, Wang Yuji, Chen Tuo, Chen Yugen
The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
Jiangsu Province Key Laboratory of Tumor Systems Biology and Chinese Medicine, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
PeerJ. 2024 Dec 13;12:e18692. doi: 10.7717/peerj.18692. eCollection 2024.
Dietary therapy strategies play an important role in the treatment of pediatric patients with Crohn's disease (CD), but the relative efficacy of different dietary therapy strategies for Crohn's remission is unknown. This study aims to compare the effectiveness and tolerance of these dietary therapy strategies for active pediatric CD.
We searched the medical literature up to August 30, 2024 to identify randomized controlled trials (RCTs) of dietary therapy strategies for pediatric CD. The primary outcomes were clinical remission rate and tolerance, secondary outcomes included differences between pre- and post-treatment levels of albumin, C-reactive protein (CRP), and fecal calprotectin levels. A network meta-analysis (NMA) was performed by using the frequentist model. For binary outcome variables and continuous outcome variables, odds ratios (OR) and mean differences (MD) with corresponding 95% confidence intervals (CI) were utilized, respectively. The ranking of dietary therapy strategies was determined based on the surface under the cumulative ranking area (SUCRA) for each comparison analyzed.
Overall, 14 studies involving 564 participants were included. In terms of clinical remission rate, the partial enteral nutrition (PEN) plus Crohn's disease exclusion diet (PEN+CDED) (OR = 7.86, 95% CI [1.85-33.40]) and exclusive enteral nutrition (EEN) (OR = 3.74, 95% CI [1.30-10.76]) exhibited significant superiority over PEN alone. The tolerance of PEN+CDED was significantly higher than that of EEN (OR = 0.07, 95% CI [0.01-0.61]). According to the surface under the cumulative ranking area (SUCRA) values, the PEN+CDED intervention (90.5%) achieved the highest ranking in clinical remission rate. In terms of tolerance, PEN+CDED ranked first (88.0%), while EEN ranked last (16.3%).
In conclusion, PEN+CDED was associated with the highest clinical remission rate and tolerance among the various dietary therapy strategies evaluated. Despite limitations in the studies, this systematic review provides evidence that PEN+CDED can be used as an alternative treatment to exclusive enteral nutrition and is more suitable for long-term management in children.
饮食治疗策略在儿童克罗恩病(CD)的治疗中起着重要作用,但不同饮食治疗策略对克罗恩病缓解的相对疗效尚不清楚。本研究旨在比较这些饮食治疗策略对活动期儿童CD的有效性和耐受性。
我们检索了截至2024年8月30日的医学文献,以确定儿童CD饮食治疗策略的随机对照试验(RCT)。主要结局为临床缓解率和耐受性,次要结局包括治疗前后白蛋白、C反应蛋白(CRP)和粪便钙卫蛋白水平的差异。采用频率学派模型进行网状Meta分析(NMA)。对于二元结局变量和连续结局变量,分别使用比值比(OR)和平均差(MD)以及相应的95%置信区间(CI)。根据每个分析比较的累积排序面积(SUCRA)值确定饮食治疗策略的排名。
总体而言,纳入了14项研究,共564名参与者。在临床缓解率方面,部分肠内营养(PEN)加克罗恩病排除饮食(PEN+CDED)(OR = 7.86,95%CI [1.85 - 33.40])和全肠内营养(EEN)(OR = 3.74,95%CI [1.30 - 10.76])比单独使用PEN表现出显著优势。PEN+CDED的耐受性显著高于EEN(OR = 0.07,95%CI [0.01 - 0.61])。根据累积排序面积(SUCRA)值,PEN+CDED干预(90.5%)在临床缓解率方面排名最高。在耐受性方面,PEN+CDED排名第一(88.0%),而EEN排名最后(16.3%)。
总之,在评估的各种饮食治疗策略中,PEN+CDED的临床缓解率和耐受性最高。尽管研究存在局限性,但本系统评价提供了证据表明PEN+CDED可作为全肠内营养的替代治疗方法,并且更适合儿童的长期管理。